| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/19/2006 | EP1681063A1 Agent for improving mental disorders |
| 07/19/2006 | EP1681058A2 Pharmacologically active cns compounds |
| 07/19/2006 | EP1681055A1 Pharmaceutical preparation for the treatment of elevated homocysteine level |
| 07/19/2006 | EP1681051A1 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers |
| 07/19/2006 | EP1680963A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/19/2006 | EP1680472A2 Compounds for dual photodiagnosis and therapy |
| 07/19/2006 | EP1680413A1 New rar$g(b) receptor-activating ligand, method for the preparation thereof and use thereof in human medicine and in cosmetics |
| 07/19/2006 | EP1680140A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 07/19/2006 | EP1680136A1 Peptides having, for example, an antiangiogenic activity and applications thereof in therapeutics |
| 07/19/2006 | EP1680117A2 Use of a pyrazole derivative for preparing medicaments for the prevention and the treatment of dyslipidemia and illnesses associated with dyslipidemia and/or obesity |
| 07/19/2006 | EP1492769B1 Novel process for the preparation of 1-phenyl-2-(2-pyridyl)ethanamine |
| 07/19/2006 | EP1483284B1 Selective dipeptide inhibitors of kallikrein |
| 07/19/2006 | EP1442058B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/19/2006 | EP1395575B1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/19/2006 | EP1389137B1 Compositions for protein delivery via the pulmonary route |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1368045B1 Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1294721B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/19/2006 | EP1276880B1 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 07/19/2006 | EP1268453B1 Estrogen agonist/antagonist metabolites |
| 07/19/2006 | EP1263740B1 Pyrimidine-4-one derivative as ldl-pla2 inhibitor |
| 07/19/2006 | EP1164991A4 Gels formed by the interaction of poly(aldehyde) with various substances |
| 07/19/2006 | EP1140107B1 Agonists and antagonists of peripheral-type benzodiazepine receptors |
| 07/19/2006 | EP1056452B1 Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 07/19/2006 | CN1803837A Neurotrophic growth factor |
| 07/19/2006 | CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists |
| 07/19/2006 | CN1803184A Compound dragon's blood medicine |
| 07/19/2006 | CN1803182A Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 07/19/2006 | CN1803170A Chest pain-alleviating pills and its preparation process |
| 07/19/2006 | CN1803165A Burdock microecological formulation |
| 07/19/2006 | CN1803161A Preparation method of traditional Chinese medicine compound formulation for treating hypertension |
| 07/19/2006 | CN1803159A Drop pills for treating coronary heart disease and its preparation method |
| 07/19/2006 | CN1803158A Drop pills containing red-rooted salvia and dalbergia wood and its preparation method |
| 07/19/2006 | CN1803156A Medicine for treating apoplexy and its preparing process |
| 07/19/2006 | CN1803132A Ramatroban pharmaceutical composition |
| 07/19/2006 | CN1803032A Pure gingko liquor preparation method |
| 07/19/2006 | CN1802975A Fleece-flower tuber healthcare tea and its preparation method |
| 07/19/2006 | CN1802968A Chinese medicinal healthcare tea and its preparation method |
| 07/19/2006 | CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 07/19/2006 | CN1264846C Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 07/19/2006 | CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 07/19/2006 | CN1264840C 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands |
| 07/19/2006 | CN1264836C Benzoaxathiepin derivatives and their use in preparation of medicine |
| 07/19/2006 | CN1264824C Quinazoline derivatives |
| 07/19/2006 | CN1264821C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 07/19/2006 | CN1264570C Therapeutic use of growth factor VEGF in preparing medicine for preventing and treating endangium hyperplasia |
| 07/19/2006 | CN1264567C Garlic protein zymolysis serial product and its preparation method and use |
| 07/19/2006 | CN1264562C Chinese medicine drippling pill for treating coronary heart disease and its preparing method |
| 07/19/2006 | CN1264561C Combination of medication for curing hyperlipemia, arteriosclerosis, coronary heart disease and fatty liver |
| 07/19/2006 | CN1264559C Medicine for treating cardiovascular and cerebrovascular diseases |
| 07/19/2006 | CN1264547C Preparation of Chinese traditional medicine for treating coronary heart disease and angina as well as preparation method |
| 07/19/2006 | CN1264533C Radix salvia miltiorrhiza capsule compound and method for preparing same |
| 07/19/2006 | CN1264522C Medicinal composition, its preparation method and its use |
| 07/19/2006 | CN1264521C Nano selenium of chitin and its preparation method |
| 07/19/2006 | CN1264519C Notoginseng total saponin amino acid transfusion liquid and its producing method |
| 07/19/2006 | CN1264516C Ligustrazine phosphate dripping pill and preparation thereof |
| 07/19/2006 | CN1264511C Preparation and use of extracting protopine from plant |
| 07/19/2006 | CN1264506C preparation method of pharmaceutical combination containing red sage root element |
| 07/18/2006 | US7078566 Organic acid salts for treating tumor diseases, autoimmune diseases, cardiovascular diseases, infections, and viral diseases; nonsettling by inorganic phosphates, nontoxic to tissue, inhibition of sphingomyelinase |
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078522 2-heterocycle-7-oxo-pyrido-[2,3-d]-pyrimidines or 2-oxo-7-heterocycle-1,6-naphthyridines; phosphodiesterase V inhibitors; erectile dysfunction; side effect reduction |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078510 Robust, inducible cardiac preferred expression system for transgenesis |
| 07/18/2006 | US7078508 Anticoagulant; Dna immobilized on substrate; binding to antibody |
| 07/18/2006 | US7078438 N-(4 substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/18/2006 | US7078426 Central nervous system disorders |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078422 Activator for peroxisome proliferator-activated receptor |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078398 Compositions and methods for treating or preventing convulsions or seizures |
| 07/18/2006 | US7078390 Ribozymes to growth factor originating in human platelet |
| 07/18/2006 | US7078376 blood disorders; analgesics; nausea; cardiovascular disorders; anticancer agents; hypotensive agents; headaches; edema; diarrhea; thrombosis; reducing dosage |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078186 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of tumor disorders |
| 07/18/2006 | US7078177 Identifying modulators of oncogene receptor binding activity for treating pain, neuropathic and inflammatory, learning and memory, anxiety and cardiovascular disorders |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078052 Enhanced absorption and bioavailability |
| 07/18/2006 | US7078048 A topical formulation for treating rosacea ( a facial dermatitis ) contains a combination of: an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14 |
| 07/18/2006 | CA2364864C New metalloprotease inhibitors, the procedure for preparing them and the pharmaceutical compounds containing them |
| 07/18/2006 | CA2325781C New amino pyrrolin compounds, their preparation process and the pharmaceutical compositions therein |
| 07/13/2006 | WO2006074228A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 07/13/2006 | WO2006074199A1 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/13/2006 | WO2006073967A1 Piperidine derivatives as prodrugs of potassium channel inhibitors |
| 07/13/2006 | WO2006073413A1 Blood pressure reduction in salt-sensitive |
| 07/13/2006 | WO2006073367A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators |
| 07/13/2006 | WO2006073366A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073365A1 Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073364A1 Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073363A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073147A1 Remedial agent for fat toxicity |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |